News and Updates

The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to teplizumab, an anti-CD3 monoclonal antibody, for the prevention or delay of type 1 diabetes (T1D) in individuals at-risk of developing the disease. CD3 is a blood marker that helps to activate the immune cells—called T cells—which are thought to be responsible for the […]

Type 1 diabetes (T1D) can bring the fear of developing low blood sugar, called hypoglycemia, which can arise if someone takes too much insulin. Typically, one would take a simple carbohydrate—be it juice, candy or a glucose tablet—to bring the blood sugar back to normal range. Severe hypoglycemia means that another person—because the person with […]

Medical devices such as pacemakers and stents that can be implanted in a human body have helped many people lead healthier lives, and researchers are creating such devices for people with type 1 diabetes (T1D) with the hope that the devices can deliver and protect beta cells—the cells that produce insulin in the body—and restore […]

Thanks to the efforts of our donors and volunteers, we have made a series of top advances in 2019 type 1 diabetes research. We will continue our fight to cure type 1 diabetes (T1D) and keep our community healthy, until we reach a day when all of this is history. Read on to discover some […]

Breakthrough T1D was there when the top type 1 diabetes (T1D) experts from all over the world convened this month at the American Diabetes Association’s (ADA) Scientific Sessions in San Francisco, which was held June 7-11. Breakthrough T1D played the key roles of presenter, educator and active learner—and was the key funder and supporter of […]

The ADA’s Scientific Sessions is completed! Here, with the post-day recap, is Marlon Pragnell, Ph.D., head of the complications program at Breakthrough T1D, with a recap of type 1 diabetes complications research and results from the ADA conference:

Two leading innovators in the type 1 diabetes (T1D) space have announced a collaborative partnership aimed at enabling those with T1D to select favorite devices, knowing they all work together, even if made by different companies. The nonprofit company Tidepool announce that it is partnering with leading pump manufacturer Medtronic to create an interoperable automated […]

The American Diabetes Association’s Scientific Sessions is almost coming to a close! Here is Simi Ahmed, Ph.D., head of the immune therapy program at Breakthrough T1D, who highlights some of the important immune-based therapies and what they mean for the type 1 diabetes community:

There was some really exciting T1D prevention research in day #3, and also screening for type 1 diabetes risk. Here is Jessica Dunne, Ph.D., senior director of the prevention portfolio, who gives a recap of day in T1D prevention research:

A new artificial pancreas system that both doses and takes away insulin is showing critical benefits in helping those with type 1 diabetes maintain more consistent, and healthier, glucose levels. Two studies, shared this weekend, showed that the t:slim X2™ insulin pump with Control-IQ™ advanced hybrid closed-loop technology by Tandem® Diabetes Care resulted in more […]